Senseonics Holdings (SENS) Misses Q4 EPS by 2c, Revenues Beat; Offers FY20 Revenue Guidance Below Consensus

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. MRNA
6. SAP
7. CSX
8. LRCX
9. MRK
10. LVS

Go back to Senseonics Holdings (SENS) Misses Q4 EPS by 2c, Revenues Beat; Offers FY20 Revenue Guidance Below Consensus

Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2019 Financial Results

March 12, 2020 4:05 PM EDT

GERMANTOWN, Md.--(BUSINESS WIRE)-- Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of a long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes, today reported financial results for the fourth quarter and full year ended December 31, 2019.

Recent Highlights & Accomplishments:

Fourth Quarter total net revenue of $9.0 million OUS net revenue of $8.1 million U.S. net revenue of $0.8 million after accounting for gross to... More